India  
 
NewsR.in

'Don't panic': Top doctors on oxygen use, Remdesivir and when to visit hospital

Video Credit: HT Digital Content - Duration: 16:22s - Published
'Don't panic': Top doctors on oxygen use, Remdesivir and when to visit hospital

'Don't panic': Top doctors on oxygen use, Remdesivir and when to visit hospital

Top doctors addressed the nation on Covid-19 second surge.

Doctors advised citizens to not panic.

“No need to panic and hoard oxygen or Remdesivir,” said Dr. Randeep Guleria of AIIMS Delhi.

“Only 10-15% of people may witness severe infection.

Treat yourself with home remedies and yoga initially,” he added.

Chairman of Medanta, Dr. Naresh Trehan, Professor and HoD of Medicine AIIMS, Dr. Naveet Wig and Director General of Health Services, Dr. Sunil Kumar were also part of the discussion.

The doctors touched various issues ranging from vaccination to oxygen usage.

Watch the full video for more details.


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis [Video]

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis

A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research. #IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity ~HT.97~PR.152~

Credit: Oneindia    Duration: 03:29Published

All India Institutes of Medical Sciences All India Institutes of Medical Sciences Autonomous Indian public medical institute group

Sitaram Yechury Passes Away At the Age of 72: Know The Full Journey of CPIM Leader Here| Watch [Video]

Sitaram Yechury Passes Away At the Age of 72: Know The Full Journey of CPIM Leader Here| Watch

Sitaram Yechury, the 72-year-old General Secretary of CPM, passed away at AIIMS Delhi due to lung complications. Born in 1952, Yechury rose from student activism to lead the CPM, becoming its General Secretary in 2015. A native of Andhra Pradesh, he was educated at St. Stephen's College and JNU. Yechury's political journey included key roles in SFI and CPM. #SitaramYechury #CPM #Yechury #AIIMS #SitaramYechuryNews #RIPYechury #SIF #Worldnews #Oneindia #Oneindianews ~HT.178~PR.320~ED.101~GR.124~

Credit: Oneindia    Duration: 03:18Published

Related videos from verified sources

Remdesivir not a magic bullet: AIIMS Director [Video]

Remdesivir not a magic bullet: AIIMS Director

Amid the shortage of anti-viral drug Remdesivir in the country in wake of devastating COVID-19 situation, AIIMS (All India Institute of Medical Sciences) Director Randeep Guleria said Remdesivir is not..

Credit: ANI     Duration: 01:56Published
Top doctor explains how Covid patients can monitor oxygen at home [Video]

Top doctor explains how Covid patients can monitor oxygen at home

Medanta Chairman Dr Naresh Trehan spoke on hospitalization of Covid patients. He said,”patient's lungs' condition, blood test reports, comorbidities, and age create a scenario under which we can say..

Credit: HT Digital Content     Duration: 02:23Published
Remdesivir for those who are hospitalized, not to be procured from chemist shops: Niti Aayog [Video]

Remdesivir for those who are hospitalized, not to be procured from chemist shops: Niti Aayog

During press conference held in Delhi, Niti Aayog's Dr VK Paul spoke on Remdesivir, which is an anti-viral drug for COVID-19. "There is no question of use of Remdesivir in home setting. This is..

Credit: ANI     Duration: 02:26Published